GRN-1201

· BrightPath Biotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRN-1201, covering 2018-06-14 to 2018-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma [Phase 1]